AG真人官方

Bruker Corporation director and President & CEO Frank H. Laukien reported transactions on 08/15/2025. He received 48,431 shares of Common Stock via restricted stock units (RSUs) at no cash cost, bringing his reported direct beneficial ownership to 38,494,103 shares. The RSUs vest in four equal annual installments beginning one year after the grant.

He also was granted a stock option to purchase 137,339 shares with a $36.872 exercise price; the option vests in four equal annual installments starting 08/15/2026 and expires 08/15/2030. The filing lists several indirect holdings: 1,055,639 shares by a former spouse, 337,087 by a son, 336,607 by a daughter, and additional custodial holdings described in the form.

Busse Falko, identified as President, Biospin Group and a director/officer of Bruker Corporation (BRKR), reported equity awards granted on 08/15/2025. The filing shows 9,282 restricted stock units (RSUs) were acquired at no cash price and 8,774 stock options were granted with a $33.52 exercise price. The RSUs vest in equal installments on the first four anniversaries of the original grant date and the options vest on the same four-year schedule; the options are exercisable beginning 08/15/2026 and expire 08/15/2035. Following the reported transactions, the reporting person beneficially owns 48,171 shares of common stock and 8,774 shares underlying options. The form was signed by an attorney-in-fact on 08/19/2025.

Bruker Corporation (BRKR) reporting person Mark Munch, Executive Vice President & President of Bruker Nano Inc., received equity awards on August 15, 2025. The filing shows 23,631 restricted stock units granted and 22,337 stock options with an exercise price of $33.52. The restricted stock units vest in four equal annual installments beginning one year after the original grant date, and the stock options vest on the same four鈥憏ear schedule with an exercisability starting 08/15/2026 and expiration on 08/15/2035. After the reported transactions, Mr. Munch beneficially owns 128,443 common shares and directly holds the 22,337 shares underlying the new options.

Bruker Corporation (BRKR) reported equity awards to Executive Vice President and CFO Gerald N. Herman on 08/15/2025 consisting of 25,844 Restricted Stock Units and 24,430 stock options with an exercise price of $36.872. Following the transactions Herman beneficially owns 102,583 shares and 24,430 options. Both the RSUs and the options vest in equal installments on each of the first four anniversaries of the original grant date, and the options become exercisable beginning 08/15/2026 with an expiration date of 08/15/2035. The transactions were reported on a Form 4 under Section 16.

Bruker Corporation insider grant to its President & CEO. The filing reports that on 08/15/2025 Burkhard Prause, listed as President & CEO, was granted 5,298 Restricted Stock Units (RSUs) and 5,008 stock options with an exercise price of $33.52. The RSUs vest in four equal annual installments beginning on the first anniversary of the 08/15/2025 grant date, and the options vest on the same four-year annual schedule with an exercisable date beginning 08/15/2026 and expiration on 08/15/2035. After the RSU grant the reporting person beneficially owned 25,158 shares. The form is signed by an attorney-in-fact on 08/19/2025.

Mark Munch, Executive Vice President and President of Bruker Nano Inc., reported three non-derivative transactions in Bruker Corporation (BRKR) common stock related to restricted stock unit vesting. The Form 4 shows shares were withheld to satisfy tax withholding obligations: 1,340 shares on 08/09/2025 at $30.43, 1,107 shares on 08/10/2025 at $30.43, and 1,279 shares on 08/11/2025 at $30.78. Each transaction is reported as a direct ownership change and coded as F with the company鈥檚 explanation confirming tax withholding for RSU vesting.

Following these withholdings, the reported direct beneficial ownership amounts after each transaction were 107,198, 106,091 and 104,812 shares respectively, reflecting a total of 3,726 shares withheld across the three dates.

Frank H. Laukien, President & CEO, Director and 10% owner of Bruker Corporation (BRKR), had restricted stock units vest and had 12,917 shares withheld across three dates to satisfy tax withholding: 3,422 shares on 08/09/2025 at $30.43, 4,657 shares on 08/10/2025 at $30.43, and 4,838 shares on 08/11/2025 at $30.78. The transactions are coded F, indicating company withholding rather than open-market sales.

Following the withholdings, his reported direct beneficial ownership was about 38.45 million shares (38,445,672 after the 08/11 transaction). The filing also lists indirect holdings including 1,055,639 shares by a former spouse and various family/UTMA holdings, showing structured family ownership but no additional dispositions reported.

Herman Gerald N., Executive Vice President and CFO of Bruker Corporation, reported the withholding of vested restricted stock units to satisfy tax obligations. The Form 4 shows three withholding transactions over August 9鈥�11, 2025: 1,846 shares on 08/09 at $30.43, 1,380 shares on 08/10 at $30.43, and 1,420 shares on 08/11 at $30.78. The company鈥檚 explanatory note states these shares were withheld to cover taxes arising from vesting of previously granted RSUs.

Following the reported transactions, the filing lists beneficial ownership declining across those dates to 79,539, then 78,159, and finally 76,739 shares held directly by the reporting person. These entries are recorded under Transaction Code F and are presented as direct ownership on the Form 4.